Graft-versus-host disease (GvHD): Advances at EBMT 2016
How can BCMA be used as a target for mutiple myeloma treatment?
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel
Measuring treatment response rates in multiple myeloma
Changing the strategy: early treatment for improved survival in MM